ADA CST5 was identified as the optimal biomarker for traumatic brain injury (TBI) due to its ability to differentiate between mild and severe injuries within the first hour of injury, effectively identifying patients with severe TBI from all other cohorts91. This evidence concerns the gene CST5 and brain injury.